176 related articles for article (PubMed ID: 23516486)
1. Structural insights into the mechanism of phosphoregulation of the retinoblastoma protein.
Lamber EP; Beuron F; Morris EP; Svergun DI; Mittnacht S
PLoS One; 2013; 8(3):e58463. PubMed ID: 23516486
[TBL] [Abstract][Full Text] [Related]
2. The retinoblastoma protein modulates Tbx2 functional specificity.
Vance KW; Shaw HM; Rodriguez M; Ott S; Goding CR
Mol Biol Cell; 2010 Aug; 21(15):2770-9. PubMed ID: 20534814
[TBL] [Abstract][Full Text] [Related]
3. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein.
Hirschi A; Cecchini M; Steinhardt RC; Schamber MR; Dick FA; Rubin SM
Nat Struct Mol Biol; 2010 Sep; 17(9):1051-7. PubMed ID: 20694007
[TBL] [Abstract][Full Text] [Related]
4. A Strategy for Direct Chemical Activation of the Retinoblastoma Protein.
Pye CR; Bray WM; Brown ER; Burke JR; Lokey RS; Rubin SM
ACS Chem Biol; 2016 May; 11(5):1192-7. PubMed ID: 26845289
[TBL] [Abstract][Full Text] [Related]
5. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.
Iwahori S; Hakki M; Chou S; Kalejta RF
J Biol Chem; 2015 Aug; 290(32):19666-80. PubMed ID: 26100623
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture.
Hassler M; Singh S; Yue WW; Luczynski M; Lakbir R; Sanchez-Sanchez F; Bader T; Pearl LH; Mittnacht S
Mol Cell; 2007 Nov; 28(3):371-85. PubMed ID: 17996702
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of retinoblastoma protein phosphorylation in gingiva after cyclosporine A treatment: an in vivo and in vitro study.
Chiang CY; Tu HP; Chen YT; Chin YT; Lai TM; Chiu HC; Nieh S; Fu E
J Periodontal Res; 2011 Apr; 46(2):158-63. PubMed ID: 21198643
[TBL] [Abstract][Full Text] [Related]
8. RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.
Indovina P; Pentimalli F; Casini N; Vocca I; Giordano A
Oncotarget; 2015 Jul; 6(20):17873-90. PubMed ID: 26160835
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the retinoblastoma protein phosphorylation code.
Rubin SM
Trends Biochem Sci; 2013 Jan; 38(1):12-9. PubMed ID: 23218751
[TBL] [Abstract][Full Text] [Related]
10. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
[TBL] [Abstract][Full Text] [Related]
11. The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells.
Gubern A; Joaquin M; Marquès M; Maseres P; Garcia-Garcia J; Amat R; González-Nuñez D; Oliva B; Real FX; de Nadal E; Posas F
Mol Cell; 2016 Oct; 64(1):25-36. PubMed ID: 27642049
[TBL] [Abstract][Full Text] [Related]
12. The Rb1 tumour suppressor gene modifies telomeric chromatin architecture by regulating TERRA expression.
Gonzalez-Vasconcellos I; Schneider R; Anastasov N; Alonso-Rodriguez S; Sanli-Bonazzi B; Fernández JL; Atkinson MJ
Sci Rep; 2017 Feb; 7():42056. PubMed ID: 28169375
[TBL] [Abstract][Full Text] [Related]
13. RB1 gene inactivation by chromothripsis in human retinoblastoma.
McEvoy J; Nagahawatte P; Finkelstein D; Richards-Yutz J; Valentine M; Ma J; Mullighan C; Song G; Chen X; Wilson M; Brennan R; Pounds S; Becksfort J; Huether R; Lu C; Fulton RS; Fulton LL; Hong X; Dooling DJ; Ochoa K; Mardis ER; Wilson RK; Easton J; Zhang J; Downing JR; Ganguly A; Dyer MA
Oncotarget; 2014 Jan; 5(2):438-50. PubMed ID: 24509483
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a regulatory motif that controls the exposure of specific upstream cyclin-dependent kinase sites that determine both conformation and growth suppressing activity of pRb.
Driscoll B; T'Ang A; Hu YH; Yan CL; Fu Y; Luo Y; Wu KJ; Wen S; Shi XH; Barsky L; Weinberg K; Murphree AL; Fung YK
J Biol Chem; 1999 Apr; 274(14):9463-71. PubMed ID: 10092628
[TBL] [Abstract][Full Text] [Related]
15. Understanding the antagonism of retinoblastoma protein dephosphorylation by PNUTS provides insights into the PP1 regulatory code.
Choy MS; Hieke M; Kumar GS; Lewis GR; Gonzalez-DeWhitt KR; Kessler RP; Stein BJ; Hessenberger M; Nairn AC; Peti W; Page R
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4097-102. PubMed ID: 24591642
[TBL] [Abstract][Full Text] [Related]
16. Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma.
Sachdeva UM; O'Brien JM
J Clin Invest; 2012 Feb; 122(2):425-34. PubMed ID: 22293180
[TBL] [Abstract][Full Text] [Related]
17. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases.
Zarkowska T; Mittnacht S
J Biol Chem; 1997 May; 272(19):12738-46. PubMed ID: 9139732
[TBL] [Abstract][Full Text] [Related]
18. [RB1 and CDKN2A functional defects resulting in retinoblastoma].
Babenko OV; Zemliakova VV; Saakian SV; Brovkina AF; Strel'nikov VV; Zaletaev DV; Nemtsova MV
Mol Biol (Mosk); 2002; 36(5):777-83. PubMed ID: 12391839
[TBL] [Abstract][Full Text] [Related]
19. Comparative modeling and docking studies of p16ink4/cyclin D1/Rb pathway genes in lung cancer revealed functionally interactive residue of RB1 and its functional partner E2F1.
Naqsh e Zahra S; Khattak NA; Mir A
Theor Biol Med Model; 2013 Jan; 10():1. PubMed ID: 23276293
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
